BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10766162)

  • 21. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells.
    Akhtar M; Cheng Y; Magno RM; Ashktorab H; Smoot DT; Meltzer SJ; Wilson KT
    Cancer Res; 2001 Mar; 61(6):2399-403. PubMed ID: 11289104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains.
    Zhu Y; Hua P; Lance P
    Cancer Res; 2003 Jan; 63(2):522-6. PubMed ID: 12543811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX-2 gene promoter haplotypes and prostate cancer risk.
    Panguluri RC; Long LO; Chen W; Wang S; Coulibaly A; Ukoli F; Jackson A; Weinrich S; Ahaghotu C; Isaacs W; Kittles RA
    Carcinogenesis; 2004 Jun; 25(6):961-6. PubMed ID: 14754878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
    Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
    Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
    Buecher B; Heymann MF; Blottière HM
    Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
    Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
    Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR; DuBois RN
    J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of cyclic AMP responsive element in the UVB induction of cyclooxygenase-2 transcription in human keratinocytes.
    Tang Q; Chen W; Gonzales MS; Finch J; Inoue H; Bowden GT
    Oncogene; 2001 Aug; 20(37):5164-72. PubMed ID: 11526505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New strategies for colorectal cancer prevention and treatment.
    Saha D; Roman C; Beauchamp RD
    World J Surg; 2002 Jul; 26(7):762-6. PubMed ID: 11948369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines.
    Park SW; Sung MW; Heo DS; Inoue H; Shim SH; Kim KH
    Oncogene; 2005 Oct; 24(44):6689-98. PubMed ID: 16007171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Myb regulates NOX1/p38 to control survival of colorectal carcinoma cells.
    Pekarčíková L; Knopfová L; Beneš P; Šmarda J
    Cell Signal; 2016 Aug; 28(8):924-36. PubMed ID: 27107996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of cyclooxygenase-2 expression by APC in HT-29 human colorectal carcinoma cells.
    Hsi LC; Angerman-Stewart J; Eling TE
    Adv Exp Med Biol; 2002; 507():127-31. PubMed ID: 12664576
    [No Abstract]   [Full Text] [Related]  

  • 35. Promoter methylation regulates cyclooxygenase expression in breast cancer.
    Ma X; Yang Q; Wilson KT; Kundu N; Meltzer SJ; Fulton AM
    Breast Cancer Res; 2004; 6(4):R316-21. PubMed ID: 15217498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition.
    Sakuma K; Sasaki E; Hosoda W; Komori K; Shimizu Y; Yatabe Y; Aoki M
    Cancer Sci; 2021 Sep; 112(9):3846-3855. PubMed ID: 34286904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2.
    Howe LR; Crawford HC; Subbaramaiah K; Hassell JA; Dannenberg AJ; Brown AM
    J Biol Chem; 2001 Jun; 276(23):20108-15. PubMed ID: 11274170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular mechanisms involved in colon carcinogenesis].
    Kannagi R
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():61-6. PubMed ID: 14574856
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclooxygenase expression in canine platelets and Madin-Darby canine kidney cells.
    Kay-Mugford PA; Benn SJ; LaMarre J; Conlon PD
    Am J Vet Res; 2000 Dec; 61(12):1512-6. PubMed ID: 11131590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer.
    Church RD; Yu J; Fleshman JW; Shannon WD; Govindan R; McLeod HL
    Br J Cancer; 2004 Sep; 91(6):1015-8. PubMed ID: 15328521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.